Description

Dihydrodiol Ibrutinib CAS NO 1654820-87-7 is a key pharmaceutical intermediate and metabolite of the active drug Ibrutinib. This compound is critical for research and development in the field of targeted cancer therapies, particularly for B-cell malignancies. It is primarily utilized by pharmaceutical manufacturers and research institutions engaged in the synthesis, metabolism studies, and impurity profiling of Bruton's tyrosine kinase (BTK) inhibitors.

Application

• Pharmaceutical Intermediate: A crucial building block in the synthesis and research-scale production of Ibrutinib and related analogs.
• Metabolite Reference Standard: Used as an analytical standard in pharmacokinetic and drug metabolism studies to understand Ibrutinib's biotransformation pathways.
• Impurity Profiling: Essential for the identification and quantification of process-related impurities and degradation products in Ibrutinib Active Pharmaceutical Ingredient (API) batches to ensure drug safety and quality.
• Bioanalytical Research: Serves as a reference compound in the development and validation of LC-MS/MS and HPLC methods for biological sample analysis.
• Preclinical & Clinical Research: Supports investigative studies on the efficacy, safety, and mechanism of action of BTK inhibitor therapies.
• Regulatory Compliance: Used to prepare documentation for regulatory submissions (e.g., to FDA, EMA) requiring detailed impurity and metabolite characterization.

Basic Information

Product Name	Dihydrodiol Ibrutinib
CAS No.	1654820-87-7
Molecular Formula	C25H27N5O5
Molecular Weight	477.51 g/mol
Synonyms	(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-2,6-dione; Ibrutinib Dihydrodiol; Ibrutinib Metabolite; PCI-45227; (R)-Ibrutinib Dihydrodiol; 1-[(3R)-2,6-Dioxopiperidin-3-yl]-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine; BTK Inhibitor Metabolite
EINECS	Contact for details

Quality Control

Our Dihydrodiol Ibrutinib is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, MS), to ensure it meets the high standards required for pharmaceutical research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting key parameters such as assay, chiral purity, and related substances.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual unknown impurity ≤ 0.5% Total impurities ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.